Hawk Trade says that it remains committed to seeking value in the biotechnology space despite rising concerns of a bubble in the sector.
Tokyo-based broker-dealer, Hawk Trade says it remains bullish on the prospects for the biotechnology investment space despite growing fears over a co-called “bubble” in the market.
The spate of biotech IPOs in recent years has been overshadowed to some extent by a similar fervor for stocks in the internet and social media segments but more commentators are suggesting that there is cause for concern as equity values continue to rise to record levels with little in the way of fundamental underpinnings.
A Hawk Trade analyst said, “Biotech remains one of the most exciting sectors in the investment landscape right now because of all the innovations and treatments that have empirical evidence backing them up. Biotech is not like social media where companies like, say, Twitter who have only ever lost money, are able to raise billions of dollars on the stock market.”
The Hawk Trade added, “We’ve invested in innovative companies like Gerontology Solutions, which will soon formally unveil an affordable treatment which literally stimulates the skin to produce collagen.”
According to Hawk Trade, the Gerontology Solutions treatment – code-named ‘Regenoderm’ – will effectively achieve the ultimate objective of the cosmetics industry.
“Obviously, while we fully recognize that there is a great deal of activity in the equity markets at the moment, we have no doubt whatsoever that the conduct of careful due diligence on a biotech company prior to committing resources will always offer investors a safety net and a solid base from which to rebound in the event of a wider stock market correction,” concluded the Hawk Trade analyst.
About Hawk Trade:
Since our inception in 2007, Hawk Trade has focused on delivering exceptional investment performance to our clients both corporate and individual, by coupling entrepreneurial drive with deep industry expertise and robust risk management.
About Gerontology Solutions:
Gerontology Solutions is dedicated to developing and marketing small-molecule therapeutics derived from genetic and phosphatase platforms and nutritional health supplements that help maintain vigour and functionality as we age.
Through research on protein networks that control biological systems, Gerontology Solutions is developing therapeutic agents for Alzheimer’s, Parkinson’s and other neurodegenerative diseases. Our technology provides many opportunities for the development of innovative pharmaceutical therapeutics.
Hawk Trade Contact Details:
Tokyo Daiya Building No. 5, Level 8,
1-28-23 Shinkawa,
Tokyo,
Tokyo-to
Japan
Phone: +81345782731
Fax: +81368003062
Email: info@hawktrade.co
Website: http://www.hawktrade.com